Erlotinib resistance in lung cancer cells mediated by integrin β1/Src/Akt-driven bypass signaling.
Kanda R, Kawahara A, Watari K, Murakami Y, Sonoda K, Maeda M, Fujita H, Kage M, Uramoto H, Costa C, Kuwano M, Ono M.
Kanda R, et al. Among authors: kuwano m.
Cancer Res. 2013 Oct 15;73(20):6243-53. doi: 10.1158/0008-5472.CAN-12-4502. Epub 2013 Jul 19.
Cancer Res. 2013.
PMID: 23872583